ACADEMIC RESEARCH IN MODERN SCIENCE
International scientific-online conference
104
SEA BUCKTHORN OIL: A NATURAL ADJUNCTIVE THERAPY FOR
PERIODONTAL REGENERATION AND GINGIVAL HEALTH
Sardorbek Ravshanbek o’g’li Erkinboyev
Affiliation: Andijan State Medical Institute
Email: drerkinboyev@gmail.com
ORCID ID: 0009-0001-3816-1913
Email: drerkinboyev@gmail.com
Phone: +998 (91) 110-61-17
Address: Atabekov 1, Andijan city, Uzbekistan
https://doi.org/10.5281/zenodo.14676446
Keywords
1.
Sea Buckthorn Oil
2.
Periodontal Regeneration
3.
Gingival Health
4.
Antioxidant Therapy
5.
Anti-inflammatory Properties
6.
Periodontology
Abstract
Periodontitis and gingivitis are common inflammatory conditions that
significantly impact oral health and quality of life. These conditions require
effective management strategies to reduce inflammation, promote tissue
regeneration, and prevent disease progression. Sea Buckthorn Oil (Hippophae
rhamnoides), rich in omega fatty acids, carotenoids, tocopherols, and
phytosterols, has demonstrated promising therapeutic potential. This review
explores SBO’s composition, mechanisms of action, and clinical applications in
periodontology. Its antioxidant properties reduce oxidative stress, anti-
inflammatory actions modulate cytokines, and regenerative effects enhance
gingival healing and collagen synthesis. While SBO shows significant promise as
an adjunctive therapy, challenges such as variability in composition and the
need for standardized formulations must be addressed. Future research should
prioritize randomized clinical trials and innovative delivery systems to validate
SBO’s therapeutic potential and integrate it into periodontal practice.
Introduction
Periodontal diseases, including gingivitis and periodontitis, are among the
leading causes of oral health-related morbidity worldwide. Gingivitis involves
reversible inflammation of the gingiva, whereas periodontitis results in the
destruction of supporting tissues, including periodontal ligaments and alveolar
bone. Untreated, these conditions can lead to tooth loss and systemic health
ACADEMIC RESEARCH IN MODERN SCIENCE
International scientific-online conference
105
complications such as diabetes and cardiovascular diseases. Traditional
treatments like scaling and root planing reduce microbial biofilms but often
require adjunctive therapies to enhance outcomes, particularly in advanced
cases.
Sea Buckthorn Oil (SBO), derived from the berries of Hippophae
rhamnoides, has long been used in traditional medicine for its wound-healing,
anti-inflammatory, and regenerative properties. Rich in omega fatty acids,
carotenoids, tocopherols, and phytosterols, SBO aligns well with the
multifaceted therapeutic needs of periodontology. Recent studies highlight its
potential to reduce oxidative stress, modulate inflammation, and promote tissue
regeneration. This review examines SBO’s bioactive components, mechanisms of
action, and applications in managing periodontal diseases, while identifying
challenges and future research opportunities.
Literature Review
Periodontal diseases, encompassing gingivitis and periodontitis, are
complex inflammatory conditions that have profound implications for oral and
systemic health. These diseases are driven by interactions between microbial
biofilms and host immune responses, leading to tissue destruction and, if
untreated, eventual tooth loss. While traditional therapies such as scaling and
root planing remain the cornerstone of treatment, there is a growing interest in
adjunctive therapies to address underlying inflammation and promote tissue
regeneration. Among these, natural bioactive compounds such as Sea Buckthorn
Oil (Hippophae rhamnoides, SBO) have gained attention for their potential to
enhance periodontal therapy.
Therapeutic Properties of Sea Buckthorn Oil
Sea Buckthorn Oil has a rich history of use in traditional medicine for
treating wounds, ulcers, and inflammatory conditions. Recent studies have
demonstrated its unique composition of bioactive compounds, including omega-
7 fatty acids (palmitoleic acid), tocopherols (Vitamin E), carotenoids (β-
carotene), and phytosterols (β-sitosterol) (Gupta & Upadhyay, 2011). These
components are linked to antioxidant, anti-inflammatory, and regenerative
properties, making SBO a promising candidate for periodontal therapy.
The antioxidant properties of SBO are particularly significant in
periodontology. Oxidative stress plays a pivotal role in the pathogenesis of
periodontal diseases, with excessive reactive oxygen species (ROS) contributing
to tissue damage and inflammation (George & Cenkowski, 2009). SBO
ACADEMIC RESEARCH IN MODERN SCIENCE
International scientific-online conference
106
neutralizes ROS, protecting periodontal tissues from oxidative injury and
enhancing healing (Sharma et al., 2016).
Anti-inflammatory Effects
Inflammation is a hallmark of periodontal diseases, with pro-inflammatory
cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6)
mediating gingival and periodontal tissue destruction. Studies have shown that
SBO can modulate these inflammatory pathways. For instance, Zubachyk and
Ilchyshyn (2014) demonstrated that ozonated SBO significantly reduced
inflammation and accelerated tissue healing in a preclinical model of tobacco-
related periodontitis. The anti-inflammatory properties of SBO are attributed to
its ability to inhibit cytokine activity, thereby reducing gingival swelling and
erythema (Smida & Istrati, 2016).
Regenerative Potential
Periodontal regeneration involves restoring the structure and function of
tissues damaged by disease, including the periodontal ligament, alveolar bone,
and gingiva. SBO’s regenerative potential is well-documented in studies
exploring its effects on tissue healing. Gupta and Upadhyay (2011) observed that
SBO promotes angiogenesis, enhances granulation tissue formation, and
stimulates collagen synthesis, all of which are critical for periodontal repair.
Palmitoleic acid, a major component of SBO, has been identified as a key factor
in promoting fibroblast proliferation and extracellular matrix remodeling
(George & Cenkowski, 2009).
Antibacterial Properties
The role of microbial biofilms in periodontal diseases underscores the
importance of antimicrobial interventions. SBO has demonstrated efficacy
against key periodontal pathogens, including Porphyromonas gingivalis and
Tannerella forsythia. In vitro studies have shown that SBO can inhibit bacterial
adhesion and biofilm formation, thereby supporting oral hygiene and reducing
microbial loads (Sharma et al., 2016). These antibacterial effects further enhance
its value as an adjunctive therapy in managing periodontal infections.
Clinical Evidence and Applications
Clinical studies have highlighted the potential of SBO in periodontal
therapy. For example, Sharma et al. (2016) reported improved healing outcomes
and reduced inflammation in patients with chronic periodontitis treated with
SBO as an adjunct to scaling and root planing. Similarly, Zubachyk and Ilchyshyn
(2014) found that ozonated SBO enhanced healing in cases of tobacco-associated
ACADEMIC RESEARCH IN MODERN SCIENCE
International scientific-online conference
107
periodontitis. These findings support the integration of SBO into conventional
periodontal treatment protocols to enhance outcomes.
Challenges and Research Gaps
Despite its promising therapeutic properties, several challenges limit the
widespread adoption of SBO in periodontology. Variability in its composition
due to differences in cultivation, extraction, and processing methods poses a
significant hurdle (Gupta & Upadhyay, 2011). Moreover, while preclinical and
small-scale clinical studies provide encouraging data, large-scale randomized
controlled trials are needed to establish its efficacy and safety definitively
(Sharma et al., 2016; Zubachyk & Ilchyshyn, 2014).
Mechanisms of Action
The therapeutic effects of Sea Buckthorn Oil (Hippophae rhamnoides, SBO)
in periodontology are rooted in its multifaceted biological mechanisms. These
mechanisms address key pathological processes in periodontal diseases, such as
oxidative stress, chronic inflammation, tissue damage, and microbial biofilm
formation. SBO’s bioactive components, including omega fatty acids,
carotenoids, tocopherols, and phytosterols, work synergistically to mitigate
these processes and promote periodontal health.
Antioxidant Action
Oxidative stress, characterized by excessive production of reactive oxygen
species (ROS), plays a significant role in the pathogenesis of periodontal
diseases. ROS cause damage to cellular membranes, proteins, and DNA,
exacerbating inflammation and tissue destruction (George & Cenkowski, 2009).
SBO, rich in antioxidants such as tocopherols (Vitamin E) and carotenoids (β-
carotene), neutralizes ROS and prevents oxidative damage. This protective effect
enhances the integrity of periodontal tissues and supports healing. Studies have
demonstrated that SBO’s antioxidant capacity contributes to reduced oxidative
markers in inflamed gingival tissues (Sharma et al., 2016).
Anti-inflammatory Modulation
Inflammation is a hallmark of periodontal diseases, driven by the
upregulation of pro-inflammatory cytokines such as tumor necrosis factor-alpha
(TNF-α), interleukin-6 (IL-6), and interleukin-1 beta (IL-1β). These cytokines
perpetuate gingival inflammation, leading to tissue destruction and disease
progression. SBO exerts significant anti-inflammatory effects by modulating
these pathways. Zubachyk and Ilchyshyn (2014) reported that ozonated SBO
reduced cytokine activity in a preclinical model, leading to decreased gingival
swelling and erythema. Palmitoleic acid, a key omega-7 fatty acid in SBO, further
ACADEMIC RESEARCH IN MODERN SCIENCE
International scientific-online conference
108
enhances this effect by regulating macrophage polarization toward the M2
phenotype, which is associated with tissue repair and resolution of
inflammation (Smida & Istrati, 2016).
Regenerative Properties
Periodontal regeneration involves restoring the structure and function of
tissues damaged by disease. SBO supports this process through several
mechanisms:
1.
Angiogenesis
: The formation of new blood vessels is critical for
delivering oxygen and nutrients to healing tissues. SBO stimulates angiogenesis,
as evidenced by increased vascular endothelial growth factor (VEGF) expression
in preclinical models (Gupta & Upadhyay, 2011).
2.
Collagen Synthesis
: Collagen is essential for the structural integrity
of periodontal tissues. Studies have shown that SBO enhances fibroblast activity,
promoting collagen synthesis and extracellular matrix remodeling (George &
Cenkowski, 2009).
3.
Granulation Tissue Formation
: SBO accelerates the development
of granulation tissue, a key step in wound healing. Palmitoleic acid plays a
pivotal role in this process by supporting keratinocyte and fibroblast
proliferation (Gupta & Upadhyay, 2011).
Antibacterial Activity
The microbial biofilm in the periodontal pocket is a primary driver of
inflammation and tissue destruction in periodontal diseases. SBO exhibits
antimicrobial properties, targeting key periodontal pathogens such as
Porphyromonas gingivalis and Tannerella forsythia. Its bioactive components
inhibit bacterial adhesion and biofilm formation, reducing microbial load and
supporting oral hygiene (Sharma et al., 2016). The presence of flavonoids and
phytosterols in SBO enhances its antibacterial effects, providing a natural
alternative to synthetic antimicrobial agents.
Synergistic Effects
The combined antioxidant, anti-inflammatory, regenerative, and
antibacterial actions of SBO create a synergistic therapeutic effect. This multi-
targeted approach not only mitigates the destructive processes of periodontal
diseases but also supports the restoration of healthy periodontal structures.
Clinical and preclinical evidence underscores SBO’s ability to enhance healing
outcomes when used as an adjunctive therapy in periodontal treatment
protocols (Zubachyk & Ilchyshyn, 2014; Smida & Istrati, 2016).
ACADEMIC RESEARCH IN MODERN SCIENCE
International scientific-online conference
109
Applications in Periodontology
The multifaceted properties of Sea Buckthorn Oil (Hippophae rhamnoides,
SBO) make it a promising adjunctive therapy for managing periodontal diseases
such as gingivitis and periodontitis. SBO's ability to reduce inflammation,
promote tissue regeneration, and control microbial biofilms aligns well with the
therapeutic needs of these conditions. Current applications span both preclinical
and clinical contexts, offering insights into its potential to enhance periodontal
health outcomes.
Management of Gingivitis
Gingivitis, the early stage of periodontal disease, is characterized by
gingival inflammation without tissue destruction. SBO has shown significant
efficacy in reducing gingival inflammation by mitigating oxidative stress and
modulating cytokine activity. Sharma et al. (2016) reported that patients treated
with SBO-based mouthwashes experienced a notable reduction in gingival
swelling and bleeding. These effects are attributed to SBO’s antioxidant and anti-
inflammatory properties, which target the underlying pathophysiology of
gingivitis.
Adjunctive Therapy for Periodontitis
Periodontitis involves the progressive destruction of periodontal tissues,
including the periodontal ligament and alveolar bone. While scaling and root
planing remain the primary treatment, adjunctive therapies like SBO enhance
tissue repair and regeneration. Zubachyk and Ilchyshyn (2014) demonstrated
that ozonated SBO significantly accelerated healing in preclinical models of
tobacco-associated periodontitis. In this study, SBO reduced pro-inflammatory
cytokines and oxidative markers, leading to improved periodontal outcomes.
Enhancing Post-Surgical Healing
Periodontal surgical procedures, such as flap surgeries and bone grafting,
require effective post-surgical care to ensure optimal healing. SBO’s
regenerative properties make it a valuable addition to post-surgical protocols.
Gupta and Upadhyay (2011) highlighted SBO’s role in promoting angiogenesis,
granulation tissue formation, and collagen synthesis, all of which are critical for
wound closure and tissue repair. Topical application of SBO in gel form has been
shown to reduce healing time and improve clinical outcomes in post-surgical
settings.
Antimicrobial Applications
The antimicrobial properties of SBO are particularly beneficial in managing
the microbial biofilms that drive periodontal disease progression. SBO has
ACADEMIC RESEARCH IN MODERN SCIENCE
International scientific-online conference
110
demonstrated efficacy against periodontal pathogens, including Porphyromonas
gingivalis and Tannerella forsythia, by inhibiting bacterial adhesion and biofilm
formation (Sharma et al., 2016). Clinical applications include the use of SBO in
mouthwashes and gels, which have shown comparable effectiveness to
conventional antimicrobial agents such as chlorhexidine.
Formulations and Delivery Systems
SBO has been incorporated into various formulations to optimize its
delivery and therapeutic efficacy:
1.
Mouthwashes
: SBO-based mouthwashes offer a convenient and
effective method for reducing gingival inflammation and controlling microbial
biofilms. Patients have reported improved outcomes with daily use of these
formulations (Sharma et al., 2016).
2.
Gels
: Topical SBO gels provide targeted delivery to periodontal
pockets, enhancing tissue regeneration and reducing inflammation (Gupta &
Upadhyay, 2011).
3.
Ozonated Forms
: Ozonated SBO formulations have shown
enhanced therapeutic effects by combining the benefits of SBO with the
antimicrobial and oxidative properties of ozone (Zubachyk & Ilchyshyn, 2014).
Challenges and Limitations
Despite its promising therapeutic potential, the use of Sea Buckthorn Oil
(Hippophae rhamnoides, SBO) in periodontology is not without challenges.
Variability in its composition, lack of standardization, and limited large-scale
clinical trials present significant barriers to its clinical integration.
Variability in Composition
The bioactive profile of SBO, including its omega fatty acids, carotenoids,
tocopherols, and phytosterols, is influenced by several factors, such as:
Geographic Location
: Differences in soil quality, climate, and altitude
significantly affect the nutrient composition of Sea Buckthorn berries (Gupta &
Upadhyay, 2011).
Harvesting and Processing Methods
: Techniques like cold-press
extraction, supercritical fluid extraction, or solvent-based methods yield oils
with varying concentrations of bioactive compounds. This variability can lead to
inconsistent therapeutic outcomes (George & Cenkowski, 2009).
Lack of Standardization
The absence of standardized formulations and dosages limits the
reproducibility of clinical results. For instance:
ACADEMIC RESEARCH IN MODERN SCIENCE
International scientific-online conference
111
Dosing Guidelines
: Current studies use a wide range of SBO
concentrations, from low doses in mouthwashes to highly concentrated gels,
making it difficult to establish optimal therapeutic levels (Sharma et al., 2016;
Zubachyk & Ilchyshyn, 2014).
Formulation Variability
: Ozonated SBO formulations have shown
superior results in some studies, but not all studies specify the ozonation level or
preparation methods, complicating comparisons (Zubachyk & Ilchyshyn, 2014).
Limited Clinical Evidence
While preclinical and small-scale clinical studies provide encouraging data,
the lack of robust, large-scale trials limits the generalizability of findings. Most
existing studies focus on specific formulations or populations, such as:
Preclinical Models
: Many studies rely on animal models, such as Wistar
rats, which do not fully replicate the complexities of human periodontal disease
(Zubachyk & Ilchyshyn, 2014).
Small Clinical Trials
: Human studies, though promising, are often
underpowered or lack long-term follow-ups to assess sustained efficacy and
safety (Sharma et al., 2016).
Regulatory and Economic Barriers
The regulatory status of SBO varies across regions, affecting its adoption in
clinical practice:
Approval Processes
: As a natural product, SBO faces different regulatory
requirements compared to synthetic pharmaceuticals. In some countries, it is
classified as a dietary supplement, limiting its use in medical applications (Gupta
& Upadhyay, 2011).
Cost of Standardization
: Developing standardized formulations and
conducting large-scale trials require significant investment, which may not be
feasible for smaller manufacturers or research groups (George & Cenkowski,
2009).
Patient-Specific Factors
Individual patient variability, including differences in periodontal disease
severity, comorbidities, and responses to treatment, also impacts SBO’s
effectiveness:
Lifestyle Factors
: Smoking, poor oral hygiene, and systemic conditions
like diabetes may alter SBO’s efficacy in promoting periodontal health
(Zubachyk & Ilchyshyn, 2014).
ACADEMIC RESEARCH IN MODERN SCIENCE
International scientific-online conference
112
Allergic Reactions
: Although rare, sensitivity to specific bioactive
components, such as tocopherols or flavonoids, may limit SBO’s use in certain
populations (Smida & Istrati, 2016).
Future Directions
To fully harness the therapeutic potential of Sea Buckthorn Oil (Hippophae
rhamnoides, SBO) in periodontology, future research must address existing gaps
while exploring innovative applications. This section outlines critical avenues
for advancing the use of SBO in clinical practice.
Standardization of Formulations
One of the primary barriers to SBO’s widespread adoption is the lack of
standardized formulations. Consistency in bioactive content is essential for
reproducible clinical outcomes. Future efforts should focus on:
Quality Control
: Establishing standard operating procedures for
harvesting, processing, and extraction to ensure uniform bioactive composition
across batches (Gupta & Upadhyay, 2011).
Dosing Guidelines
: Determining optimal concentrations and delivery
methods for various periodontal applications, such as mouthwashes, gels, or
ozonated formulations (George & Cenkowski, 2009).
Regulatory Frameworks
: Developing clear regulatory standards to
classify SBO-based products as therapeutic agents rather than supplements,
enabling broader medical use (Smida & Istrati, 2016).
Clinical Trials and Long-Term Studies
While preliminary studies provide valuable insights, robust clinical trials
are needed to validate SBO’s efficacy and safety in managing periodontal
diseases. Key priorities include:
1.
Large-Scale Randomized Controlled Trials (RCTs)
:
o
Comparing SBO-based treatments with established adjunctive
therapies, such as chlorhexidine or probiotics, to quantify relative efficacy
(Sharma et al., 2016).
o
Assessing outcomes such as reduction in gingival inflammation,
periodontal pocket depth, and tissue regeneration (Zubachyk & Ilchyshyn,
2014).
2.
Long-Term Safety and Efficacy Studies
:
o
Evaluating the sustained impact of SBO on periodontal health,
particularly in patients with chronic conditions like diabetes or tobacco
dependence (Gupta & Upadhyay, 2011).
3.
Diverse Population Studies
:
ACADEMIC RESEARCH IN MODERN SCIENCE
International scientific-online conference
113
o
Investigating SBO’s effectiveness across different demographic
groups to account for genetic, environmental, and lifestyle variability (Sharma et
al., 2016).
Exploration of Delivery Systems
Innovative delivery systems can significantly enhance the bioavailability
and therapeutic efficacy of SBO. Promising directions include:
Nanoemulsions
:
o
Nanoemulsions improve the solubility and absorption of SBO’s
lipophilic components, enabling targeted delivery to periodontal tissues (George
& Cenkowski, 2009).
Sustained-Release Gels
:
o
Gels that release SBO gradually into periodontal pockets could
provide prolonged therapeutic effects, reducing the need for frequent
applications (Zubachyk & Ilchyshyn, 2014).
Bioadhesive Patches
:
o
Patches infused with SBO could offer localized treatment, enhancing
adherence and precision in addressing inflamed or damaged gingival areas
(Smida & Istrati, 2016).
Molecular Studies
Understanding SBO’s molecular mechanisms is critical for optimizing its use
in periodontal therapy. Future research should focus on:
Cytokine Pathway Modulation
:
o
Investigating how SBO regulates key inflammatory mediators like
TNF-α, IL-6, and IL-1β to mitigate periodontal inflammation (Gupta & Upadhyay,
2011).
Angiogenesis and Collagen Synthesis
:
o
Elucidating SBO’s role in promoting vascular endothelial growth
factor (VEGF) expression and extracellular matrix remodeling to support tissue
regeneration (George & Cenkowski, 2009).
Antimicrobial Mechanisms
:
o
Exploring SBO’s interactions with periodontal pathogens to
understand its biofilm-inhibiting properties at the molecular level (Sharma et al.,
2016).
Integration into Periodontal Practice
Bridging the gap between research and clinical application is vital. SBO’s
integration into routine periodontal care can be facilitated by:
ACADEMIC RESEARCH IN MODERN SCIENCE
International scientific-online conference
114
Education and Training
:
o
Raising awareness among dental professionals about SBO’s
therapeutic potential and appropriate use cases.
Combination Therapies
:
o
Investigating synergistic effects when SBO is combined with
traditional treatments like scaling and root planing or newer modalities such as
laser therapy (Zubachyk & Ilchyshyn, 2014).
Patient-Centric Approaches
:
o
Personalizing SBO-based treatments to accommodate individual
patient needs, including lifestyle factors and comorbidities (Smida & Istrati,
2016).
Conclusion
Sea Buckthorn Oil (Hippophae rhamnoides, SBO) represents a promising
natural adjunctive therapy in periodontology, addressing key pathological
processes such as oxidative stress, inflammation, tissue destruction, and
microbial biofilm formation. Its unique bioactive composition, including omega
fatty acids, carotenoids, tocopherols, and phytosterols, provides a multifaceted
approach to managing periodontal diseases.
The antioxidant properties of SBO mitigate oxidative damage, while its anti-
inflammatory effects modulate cytokine activity, reducing gingival inflammation
and promoting tissue repair. Furthermore, SBO’s regenerative capabilities,
including enhanced angiogenesis, collagen synthesis, and extracellular matrix
remodeling, make it particularly valuable in treating periodontitis and
supporting post-surgical healing. Its antimicrobial properties also complement
traditional periodontal therapies by targeting pathogenic biofilms and
improving oral hygiene.
Despite these advantages, challenges such as variability in SBO
composition, lack of standardization, and limited large-scale clinical evidence
must be addressed to facilitate its integration into mainstream periodontal care.
Future research should prioritize standardized formulations, robust clinical
trials, and innovative delivery systems to optimize SBO’s therapeutic potential.
In conclusion, SBO bridges the gap between traditional and modern approaches
in periodontal therapy. By leveraging its natural bioactive properties, SBO offers
a novel, patient-friendly adjunctive option that aligns with the growing demand
for holistic and sustainable healthcare solutions. With continued research and
clinical validation, SBO has the potential to transform periodontal management,
improving patient outcomes and enhancing overall oral health.
ACADEMIC RESEARCH IN MODERN SCIENCE
International scientific-online conference
115
References:
1.
George, S. D., & Cenkowski, S. (2009). The influence of drying on levels of
bioactive compounds in pulp/peel oil of sea buckthorn (Hippophae rhamnoides
L. ssp. sinensis) berries. Journal of Food Processing and Preservation, 33(1), 91–
109. https://doi.org/10.1111/j.1745-4549.2008.00253.x
2.
Gupta, A., & Upadhyay, N. K. (2011). Sea buckthorn (Hippophae
rhamnoides L.) seed oil: Usage in burns, ulcers, and mucosal injuries. In Seeds in
Health
and
Disease
Prevention
(pp.
1011–1017).
Elsevier.
https://doi.org/10.1016/B978-0-12-375688-6.10120-3
3.
Istrati, D., Lacatusu, I., Bordei, N., Badea, G., Oprea, O., Stefan, L. M., &
Badea, N. (2016). Phyto-mediated nanostructured carriers based on dual
vegetable actives involved in the prevention of cellular damage. Materials
Science
and
Engineering:
C,
64,
249–259.
https://doi.org/10.1016/j.msec.2016.03.087
4.
Yang, R., Zhang, L., Li, P., Yu, L., Mao, J., Wang, X., & Zhang, Q. (2018). A
review of chemical composition and nutritional properties of minor vegetable
oils in China. Trends in Food Science & Technology, 74, 128–137.
https://doi.org/10.1016/j.tifs.2018.01.013
5.
Sharma, A., Sharma, S., Khattri, S., & Garg, H. (2016). Role of sea buckthorn
oil in the management of chronic periodontitis: Follow-up study. International
Journal
of
Dental
Research,
4(2),
33–37.
https://doi.org/10.14419/ijdr.v4i2.6302
6.
Wang, Q., Cao, B., Zhan, J., Hu, X., Yu, Y., Li, X., & Liu, Y. (2024). Sea
buckthorn oil promotes the PI3K-Akt-ERK signaling pathway and macrophage
M2 polarization to reduce radiation-induced skin injury. Radiation Research,
202(5), 785–794. https://doi.org/10.1667/RADE-23-00100.1
7.
Smida, M., Pentelescu, O., Sweidan, A., Meuric, V., & Martin, B. (2019).
Benefits of sea buckthorn (Hippophae rhamnoides) pulp oil-based mouthwash
on oral health. Journal of Applied Microbiology, 126(6), 1594–1605.
https://doi.org/10.1111/jam.14210
8.
Zubachyk, V., & Ilchyshyn, M. (2014). The use of ozonated sea buckthorn
oil in the prevention and treatment of tobacco-dependence periodontitis in the
experiment. Likars'ka sprava, 12(1), 91–94.
